As we move into May, the flowers are blooming and grass pollen is flowing! This month, Annals of Allergy, Asthma & Immunology focuses on asthma. The CME review article explores the emerging role of biologic therapies for pregnant patients with asthma. Another review article explores lessons learned in the optimal use of biologics to achieve remission in severe asthma.
Did you know that most of the reviews in Annals, as well as any special articles that have clinical relevance, are available on demand from the journal’s website? When you’re logged in, scroll down on the web page and you will find Annals Collections, where these articles are curated for you – making them available when you need them! Also included in these collections are previous Marginal Zones. And speaking of Marginal Zone, this month you can play “Pin the Tail on the Inhaler.” This is a humorous look at insurance coverage for asthma inhalers, and the accompanying Cartootorial explores this issue in more detail.
Original asthma articles this month look at tezepelumab in asthma with chronic rhinosinusitis with nasal polyps (CRSwNP), clustering patients with severe asthma based on FEV1 percent changes, and the effect of particle size on distribution in inhaled triple therapies. Additional original articles look at a novel venom immunotherapy protocol, the effect of dupilumab on non-lesional skin in atopic dermatitis, the association of undetectable IgE with complications of common variable immunodeficiency, and an indirect comparison of dupilumab and tezepelumab in CRSwNP, among others.
Letters this month include studies that provide insight into the presence of eosinophils in the respiratory and digestive tract in those with uncontrolled asthma, the association of long-acting beta agonist use with increased oral food challenge reaction severity, and a look at dietary restrictions in adult food protein induced enterocolitis syndrome.
So, as you go out and smell the flowers, be sure to take your Annals with you, so that you can catch up on what is new and important in allergy and immunology! Annals’ goal is to always provide the most up-to-date information so that you can provide the best possible care to your patients. As we ask every month, if you have any comments, please email Annals (annals@ACAAI.org) with any comments (good or bad) about articles and the utility of the journal.
Mitchell H. Grayson, MD, FACAAI
Editor-in-Chief
